Articles scientifiques

Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.

Auteurs : Paternot S, Raspé E, Meiller C, Tarabichi M, Assié JB, Libert F, Remmelink M, Bisteau X, Pauwels P, Blum Y, Le Stang N, Tabone-Eglinger S, Galateau-Sallé F, Blanquart C, van Meerbeeck JP, Berghmans T, Jean D, Roger PP
Année : 2022
Journal : Mol oncol

Morphological evaluation of melanocytic lesions with three-dimensional line-field confocal optical coherence tomography: correlation with histopathology and reflectance confocal microscopy. A pilot study.

Auteurs : Perez-Anker J, Puig S, Alos L, García A, Alejo B, Cinotti E, Orte Cano C, Tognetti L, Lenoir C, Monnier J, Machuca N, Castillo P, Gibert PR, Rubegni P, Suppa M, Perrot JL, Del Marmol V, Malvehy J
Année : 2022
Journal : Clin Exp Dermatol
Volume : 47
Pages : 2222-2233

Genomics of metastatic breast cancer

Auteurs : Geukens T, De Schepper M, Richard F, Maetens M, Van Baelen K, Leduc S, Isnaldi E, Nguyen HL, Bachir I, Vandenberghe E, Van den Bogaert W, Punie K, Neven P, Wildiers H, Floris G, Desmedt C
Année : 2022
Journal : Belgian J Medical Oncology
Volume : 16(1)
Pages : 18-28

Evaluation of Cardiotoxicity in HER-2-Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab.

Auteurs : Bachir B, Anouti S, Abi Jaoude J, Kayali M, Tfayli A, de Azambuja E, Poortmans P, Zeidan YH
Année : 2022
Journal : Int J Radiat Oncol Biol Phys
Volume : 113
Pages : 135-142

Why novel mRNA modifications are so challenging and what we can do about it.

Auteurs : Penning A, Jeschke J, Fuks F
Année : 2022
Journal : Nat Rev Mol Cell Biol
Volume : 23
Pages : 385-386

Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers.

Auteurs : Furgiuele S, Descamps G, Cascarano L, Boucq A, Dubois C, Journe F, Saussez S
Année : 2022
Journal : Int J Mol Sci
Volume : 23

Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis.

Auteurs : Massaro F, Meuleman N, Bron D, Vercruyssen M, Maerevoet M
Année : 2022
Journal : Cancers (Basel)
Volume : 14

Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the My Personal Breast Screening" (MyPeBS) randomised clinical trial."

Auteurs : Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Giorgi Rossi P, Balleyguier C, Guindy M, Gilbert FJ, Burrion JB, Castells X, Ritchie D, Keatley D, Baron C, Delaloge S, de Montgolfier S
Année : 2022
Journal : BMC Cancer
Volume : 22
Pages : 507

Identification of HMGA2 as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer.

Auteurs : Spira A, Awada A, Isambert N, Lorente D, Penel N, Zhang Y, Ojalvo LS, Hicking C, Rolfe PA, Ihling C, Dussault I, Locke G, Borel C
Année : 2022
Journal : Front Oncol
Volume : 12
Pages : 981940

Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group.

Auteurs : Sclafani F, Fontana E, Wyrwicz L, Wagner AD, Valle JW, Smyth E, Peeters M, Obermannova R, Neuzillet C, Lutz MP, Koessler T, Ben-Aharon I, Arnold D, Alsina M, Moehler M
Année : 2022
Journal : Clin Colorectal Cancer
Volume : 21
Pages : 188-197

Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study.

Auteurs : Le Calvez B, Tessoullin B, Renaud L, Botella-Garcia C, Srour M, Le Gouill S, Guillerm G, Gressin R, Nguyen Quoc S, Furst S, Chauchet A, Sibon D, Lewalle P, Poiré X, Maillard N, Villate A, Loschi M, Paillassa J, Beguin Y, Dulery R, Tudesq JJ, Fayard A, Béné MC, Camus V, Chevallier P, Le Bourgeois A
Année : 2022
Journal : Acta Oncol
Volume : 61
Pages : 1332-1338

Deep Epigastric Lymph Nodes Implication in Patients' Recurrence Pattern After Cytoreductive Surgery in Colorectal Peritoneal Metastases.

Auteurs : El Asmar A, Vouche M, Galdon MG, Bali MA, Sclafani F, Donckier V, Liberale G
Année : 2022
Journal : J Gastrointest Surg
Volume : 26
Pages : 1314-1317

Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial.

Auteurs : Schwarze JK, Garaud S, Jansen YJL, Awada G, Vandersleyen V, Tijtgat J, de Wind A, Kristanto P, Seremet T, Willard-Gallo K, Neyns B
Année : 2022
Journal : Cancers (Basel)
Volume : 14

Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry.

Auteurs : Philippson C, Larsen S, Simon S, Vandekerkhove C, De Caluwe A, Van Gestel D, Chintinne M, Veys I, De Neubourg F, Noterman D, Roman M, Nogaret JM, Desmet A
Année : 2022
Journal : Breast Cancer Res
Volume : 24
Pages : 83

Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis.

Auteurs : Cau R, Solinas C, De Silva P, Lambertini M, Agostinetto E, Scartozzi M, Montisci R, Pontone G, Porcu M, Saba L
Année : 2022
Journal : Int J Cancer
Volume : 151
Pages : 1860-1873

Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE Study.

Auteurs : Baleanu F, Moreau M, Charles A, Iconaru L, Karmali R, Surquin M, Benoit F, Mugisha A, Paesmans M, Rubinstein M, Rozenberg S, Bergmann P, Body JJ
Année : 2022
Journal : J Clin Endocrinol Metab
Volume : 107
Pages : e2438-e2448

Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy.

Auteurs : Lambertini M, Fielding S, Loibl S, Janni W, Clark E, Franzoi MA, Fumagalli D, Caballero C, Arecco L, Salomoni S, Ponde NF, Poggio F, Kim HJ, Villarreal-Garza C, Pagani O, Paluch-Shimon S, Ballestrero A, Del Mastro L, Piccart M, Bines J, Partridge AH, de Azambuja E
Année : 2022
Journal : J Natl Cancer Inst
Volume : 114
Pages : 1117-1126

Cutaneous lesions of Anderson-Fabry disease examined with a novel technique: Line-field confocal optical coherence tomography.

Auteurs : Tognetti L, Cinotti E, Coriolani G, Suppa M, Perrot JL, Vascotto M, Grosso S, Rubegni P
Année : 2022
Journal : J Eur Acad Dermatol Venereol
Volume : 36
Pages : e371-e373

Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.

Auteurs : van Rees DJ, Bouti P, Klein B, Verkuijlen PJH, van Houdt M, Schornagel K, Tool ATJ, Venet D, Sotiriou C, El-Abed S, Izquierdo M, Guillaume S, Saura C, Di Cosimo S, Huober J, Roylance R, Kim SB, Kuijpers TW, van Bruggen R, K van den Berg T, Matlung HL
Année : 2022
Journal : J Immunother Cancer
Volume : 10

Unresectable and chemoresistant conjunctival squamous cell carcinoma on xeroderma pigmentosum treated by salvage radiation therapy: A case report and a review of the literature.

Auteurs : Maimouna M, Sofian B, Latifatou G, Joséphine Frédérique Mendouga E, Papa Macoumba G, Mamadou Moustapha D, Dirk VG
Année : 2022
Journal : Clin Case Rep
Volume : 10
Pages : e6360